Therapeutic opportunities for PLK1 inhibitors: Spotlight on BRCA1-deficiency and triple negative breast cancers
Article in Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (February 2020)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Bevacizumab in the neoadjuvant treatment of human epidermal growth factor receptor 2-negative breast cancer: A meta-analysis of randomized controlled trials
Article in Molecular and Clinical Oncology (January 2019)
miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1
Article in BioMed Research International (October 2015)